| 1. |
Rice TW,Blackstone EH,Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol,2010,17(7): 1721-1724.
|
| 2. |
赫捷,中國抗食管癌專業委員會. 食管癌規范化診治指南(第2版). 第2版. 北京: 中國協和醫科大學出版社,2013.
|
| 3. |
陳孝平,汪建平,吳在德,等,主編. 外科學.第8版. 北京: 人民衛生出版社,2014.
|
| 4. |
律方. 食管癌第6版AJCC分期與第七版AJCC分期的比較研究. 北京協和醫學院,2011.
|
| 5. |
Hulscher JB,van Sandick JW,de Boer AG,et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med,2002,347(21): 1662-1669.
|
| 6. |
Omloo JM,Lagarde SM,Hulscher JB,et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg,2007,246(6): 992-1001.
|
| 7. |
Sasako M,Sano T,Yamamoto S,et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol,2006,7(8): 644-651.
|
| 8. |
Kurokawa Y,Sasako M,Sano T,et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg,2015,102(4): 341-348.
|
| 9. |
Zheng Z,Cai J,Yin J,et al. Transthoracic versus abdominal-transhiatal resection for treating Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis. Int J Clin Exp Med,2015,8(10): 17167-17182.
|
| 10. |
Zhang P,Xi M,Zhao L,et al. Unilateral cervical nodal metastasis is an independent prognostic factor for esophageal squamous cell carcinoma patients undergoing chemoradiotherapy: a retrospective study. PLoS One,2014,9(6): e101332.
|
| 11. |
Chen J,Wu S,Zheng X,et al. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection. BMC Surg,2014,14: 110.
|
| 12. |
Miyata H,Yamasaki M,Miyazaki Y,et al. Clinical importance of supraclavicular lymph node metastasis after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg,2015,262(2): 280-285.
|
| 13. |
Mariette C,Piessen G,Briez N,et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg,2008,247(2): 365-371.
|
| 14. |
Groth SS,Virnig BA,Whitson BA,et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg,2010,139(3): 612-620.
|
| 15. |
Lin CS,Cheng CT,Liu CY,et al. Radical lymph node dissection in primary esophagectomy for esophageal squamous cell carcinoma. Ann Thorac Surg,2015,100(1): 278-286.
|
| 16. |
Yuan F,Qingfeng Z,Jia W,et al. Influence of metastatic status and number of removed lymph nodes on survival of patients with squamous esophageal carcinoma. Medicine (Baltimore),2015,94(48): e1973.
|
| 17. |
Peng J,Wang WP,Yuan Y,et al. Optimal extent of lymph node dissection for siewert type II esophagogastric junction adenocarcinoma. Ann Thorac Surg,2015,100(1): 263-269.
|
| 18. |
Tachimori Y,Ozawa S,Numasaki H,et al. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus,2016,13: 1-7.
|
| 19. |
van Hagen P,Hulshof MC,van Lanschot JJ,et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med,2012,366(22): 2074-2084.
|
| 20. |
Yang H,Fu JH,Liu MZ,et al. A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis. Zhonghua Yixue Zazhi,2012,92(15): 1028-1032.
|
| 21. |
Sjoquist KM,Burmeister BH,Smithers BM,et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol,2011,12(7): 681-692.
|
| 22. |
Huang TC,Hsu CH,Lin CC,et al. Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer. Jpn J Clin Oncol,2015,45(11): 1023-1028.
|
| 23. |
Wang Y,Yu Y Y,Li W,et al. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemother Pharmacol,2014,73(6): 1155-1161.
|
| 24. |
Ando N,Iizuka T,Ide H,et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol,2003,21(24): 4592-4596.
|
| 25. |
Cunningham D,Allum WH,Stenning SP,et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med,2006,355(1): 11-20.
|
| 26. |
Ychou M,Boige V,Pignon JP,et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol,2011,29(13): 1715-1721.
|
| 27. |
Ando N,Kato H,Igaki H,et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol,2012,19(1): 68-74.
|
1/5
WeChat